{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:09:19Z","timestamp":1787738959218,"version":"build-2784847793"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>Peripheral T-cell lymphoma (PTCL) comprises a heterogenous group of rare mature T-cell neoplasms. While some PTCL subtypes are well-characterized by histology, immunophenotype, and recurrent molecular alterations, others remain incompletely defined. In particular, the distinction between CD30<jats:sup>+<\/jats:sup> PTCL, not otherwise specified and anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma can be subject to disagreement. We describe a series of 6 <jats:italic toggle=\"yes\">JAK2<\/jats:italic> rearrangements occurring in a cohort of 97 CD30<jats:sup>+<\/jats:sup> ALK<jats:sup>\u2212<\/jats:sup> PTCL (6%), assembled after identifying an index case of a novel <jats:italic toggle=\"yes\">PABPC1-JAK2<\/jats:italic> fusion in a case of ALK<jats:sup>\u2212<\/jats:sup> anaplastic large cell lymphoma with unusual classic Hodgkin lymphoma (CHL)-like features. Fusions were identified using a comprehensive next-generation sequencing based assay performed between 2013 and 2020. Five of 6 cases (83%) showed <jats:italic toggle=\"yes\">JAK2<\/jats:italic> rearrangements with 4 novel partners: <jats:italic toggle=\"yes\">TFG<\/jats:italic>, <jats:italic toggle=\"yes\">PABPC1<\/jats:italic>, <jats:italic toggle=\"yes\">ILF3<\/jats:italic>, and <jats:italic toggle=\"yes\">MAP7<\/jats:italic>, and 1 case demonstrated a previously described <jats:italic toggle=\"yes\">PCM1-JAK2<\/jats:italic> fusion. By morphology, all cases showed anaplastic large cells and multinucleated Reed-Sternberg\u2013like cells within a polymorphous inflammatory background with frequent eosinophilia reminiscent of CHL. By immunohistochemistry, atypical large cells expressed CD30 with coexpression of at least 1 T-cell marker, aberrant loss of at least 1 T-cell marker and, in 4 of 5 cases stained (80%), unusual CD15 coexpression. These findings suggest that a subset of CD30<jats:sup>+<\/jats:sup> ALK<jats:sup>\u2212<\/jats:sup> systemic PTCL with anaplastic morphology carry <jats:italic toggle=\"yes\">JAK2<\/jats:italic> rearrangements, some of which appear to show CHL-like morphologic features. The presence of <jats:italic toggle=\"yes\">JAK2<\/jats:italic> rearrangements in cases of CD30<jats:sup>+<\/jats:sup> PTCL augments current classification and may provide a therapeutic target via <jats:italic toggle=\"yes\">JAK2<\/jats:italic> inhibition.<\/jats:p>","DOI":"10.1097\/pas.0000000000001708","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:42:48Z","timestamp":1616546568000},"page":"895-904","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":46,"title":["JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology"],"prefix":"10.1097","volume":"45","author":[{"given":"Megan J.","family":"Fitzpatrick","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas R.","family":"Massoth","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Marcus","sequence":"additional","affiliation":[{"name":"Foundation Medicine Inc., Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Vergilio","sequence":"additional","affiliation":[{"name":"Foundation Medicine Inc., Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Severson","sequence":"additional","affiliation":[{"name":"Foundation Medicine Inc., Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Duncan","sequence":"additional","affiliation":[{"name":"Foundation Medicine Inc., Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti H.","family":"Ramkissoon","sequence":"additional","affiliation":[{"name":"Foundation Medicine Inc., Cambridge, MA"},{"name":"Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hasserjian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliyah R.","family":"Sohani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Williams","sequence":"additional","affiliation":[{"name":"Foundation Medicine Inc., Cambridge, MA"},{"name":"Department of Pathology, Department of Dermatology, UCSF Dermatopathology Service, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":"CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3324\/haematol.2013.084913","article-title":"CD30 expression in peripheral T-cell lymphoma","volume":"98","author":"Sabattini","year":"2010","journal-title":"Haematologica"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1038\/bcj.2017.85","article-title":"Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions","volume":"7","author":"van der Weyden","year":"2017","journal-title":"Blood Cancer J"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK\u2212 anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","article-title":"Peripheral T cell lymphomas: from the bench to the clinic","volume":"20","author":"Fiore","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lmyphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12030702","article-title":"STAT3 mutation is associated with STAT3 activation in CD30+ ALK\u2212 ALCL","volume":"12","author":"Andersson","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R14-20250608","first-page":"707","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Ad\u00e9la\u00efde","year":"2017","journal-title":"Blood"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Boddicker","year":"2016","journal-title":"Blood"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood-2015-08-664649","article-title":"Integrated genomic DNA\/RNA profiling of hematologic malignancies in the clinical setting Key Points","volume":"127","author":"He","year":"2016","journal-title":"Blood"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"e1005965","DOI":"10.1371\/journal.pcbi.1005965","article-title":"A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal","volume":"7","author":"Sun","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jmoldx.2019.06.011","article-title":"A novel next-generation sequencing approach to detecting microsatellite instability and pan-tumor characterization of 1000 microsatellite instability-high cases in 67,000 patient samples","volume":"21","author":"Trabucco","year":"2019","journal-title":"J Mol Diagnostics"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2353\/jmoldx.2008.080054","article-title":"The frequency of immunoglobulin heavy chain gene and T-cell receptor \u03b3-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK\u2212 anaplastic large cell lymphoma and other peripheral T-cell lymphomas","volume":"10","author":"Tan","year":"2008","journal-title":"J Mol Diagnostics"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.leu.2404104","article-title":"A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma","volume":"20","author":"Ad\u00e9la\u00efde","year":"2006","journal-title":"Leukemia"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"e53767","DOI":"10.1371\/journal.pone.0053767","article-title":"t(8;9)(p22;p24)\/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5","volume":"8","author":"Ehrentraut","year":"2013","journal-title":"PLoS One"},{"key":"R28-20250608","first-page":"1","article-title":"Hodgkin lymphoma and cutaneous T-cell lymphoma sharing the PCM1-JAK2 fusion and a common T-cell clone","volume":"3","author":"Riedlinger","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood-2016-06-722645","article-title":"Somatic JAK2 mutations and their tumor phenotypes","volume":"128","author":"Tefferi","year":"2016","journal-title":"Blood"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2012.03.017","article-title":"Janus kinase deregulation in leukemia and lymphoma","volume":"36","author":"Chen","year":"2012","journal-title":"Immunity"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3324\/haematol.2018.215103","article-title":"Leukemia presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent critzotinib","volume":"104","author":"Graetz","year":"2019","journal-title":"Haematologica"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood.V94.9.3265","article-title":"TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma porducing two structurally different TFG-ALK translocations","volume":"94","author":"Hernandez","year":"1999","journal-title":"Blood"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/geno.1997.4625","article-title":"Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma","volume":"41","author":"Mencinger","year":"1997","journal-title":"Genomics"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/gcc.22470","article-title":"TFG-MET fusion in an infantile spindle cell sarcoma with neural features","volume":"56","author":"Flucke","year":"2017","journal-title":"Genes Chromosom Cancer"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41586-020-1970-0","article-title":"Genomic basis for RNA alterations in cancer","volume":"578","author":"Calabrese","year":"2020","journal-title":"Nature"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers resource driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1261\/rna.068619.118","article-title":"Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation","volume":"25","author":"Jia","year":"2019","journal-title":"RNA"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lungcan.2017.12.017","article-title":"EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer","volume":"116","author":"Cheng","year":"2018","journal-title":"Lung Cancer"},{"key":"R40-20250608","first-page":"1","article-title":"High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia","volume":"6","author":"Fu","year":"2016","journal-title":"Sci Rep"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41379-018-0165-9","article-title":"Hematopoietic neoplasms with 9p24\/JAK2 rearrangement: a multicenter study","volume":"32","author":"Tang","year":"2019","journal-title":"Mod Pathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/sj.leu.2403879","article-title":"PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation","volume":"19","author":"Murati","year":"2005","journal-title":"Leukemia"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14728222.2011.538683","article-title":"PCM1JAK2-fusion: a potential treatment target in myelodysplasticmyeloproliferative and other hemato-lymphoid neoplasms","volume":"15","author":"Hoeller","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jamaoncol.2018.2297","article-title":"Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors","volume":"4","author":"Ptashkin","year":"2018","journal-title":"JAMA Oncol"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamaoncol.2018.6286","article-title":"Association of JAK2 -V617F mutations detected by solid tumor sequencing with coexistent myeloproliferative neoplasms","volume":"5","author":"Riedlinger","year":"2019","journal-title":"JAMA Oncol"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1073\/pnas.1700682114","article-title":"Cytokine receptor signaling is required for the survival of ALK\u2212 anaplastic large cell lymphoma, even in the presence of JAK1\/STAT3 mutations","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00428-020-02790-z","article-title":"Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified","volume":"477","author":"Kim","year":"2020","journal-title":"Virchows Arch"},{"key":"R49-20250608","first-page":"392","article-title":"Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis","volume":"24","author":"Shen","year":"2019","journal-title":"Hematol (United Kingdom)"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/leu.2017.103","article-title":"PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma","volume":"31","author":"Atsaves","year":"2017","journal-title":"Leukemia"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:03:06Z","timestamp":1749420186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001708","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,22]]}}}